QSC RESEARCH GRADE
≥99% HPLC PurityMS ConfirmedJanoshik COAIn-House SPPS5-Region Domestic Shipping
What is PNC-27?
PNC-27 (HDM2-targeting chimeric anticancer peptide) is a 32-amino acid chimeric peptide (HDM2-binding + penetratin). Chimeric peptide combining an HDM2 (human double minute 2)-binding domain with a penetratin cell-penetrating sequence. Proposed mechanism: binds membrane-associated HDM2 overexpressed on cancer cell surfaces, disrupting p53-HDM2 interaction and inducing selective cancer cell membranolysis while sparing normal cells.
Research Applications
HDM2-p53 Disruption
Protein interaction inhibition at MDM2/HDM2-p53 interface
Cancer-Selective Lysis
Membrane-targeted anticancer peptide mechanism research
Cell Penetrating Delivery
Penetratin-mediated intracellular delivery system biology
Cancer vs Normal Cells
Selectivity mechanism — HDM2 overexpression in cancer
vs Small Molecule MDM2i
Comparison with nutlin-3, AMG-232 mechanism and selectivity
Quick Specs
| Form | Lyophilized powder |
| Purity | ≥99% by HPLC — every batch |
| CAS Number | Not publicly standardized |
| Molecular Formula | Sequence-dependent (33-amino-acid peptide) |
| Peptide Type | Synthetic Peptide / p53-MDM2 Interaction Inhibitor |
| Identity | MS molecular weight confirmed — every batch |
| COA | Janoshik-independent, publicly verifiable |
| Manufacture | In-house Fmoc SPPS — Qingdao, China |
| Storage | -20°C sealed | 2–8°C reconstituted (2–4 weeks) |
| Shelf Life | 24 months unopened |




